Treatment for telangiectasias and reticular veins

Nakano, Luis Cu; Cacione, Daniel G; Baptista-Silva, Jose CC; Flumignan, Ronald Luiz Gomes

doi:10.1002/14651858.cd012723

Cited by 13 publications

(6 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical manifestations in the initial stages of the disease are often scarce, and the more CVD progress, the more symptomatology will appear [ 47 ]. VVs are the most representative manifestation in the venous system, although reticular veins and telangiectasias might also be recognized as important clinical signs [ 48 ]. In advanced stages, the most important expression of CVI consist of the lower limb pain, usually defined as heaviness, discomfort, or pressure exacerbated at the end of the day.…”

Section: Clinical Manifestationsmentioning

confidence: 99%

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Ortega

Fraile-Martínez

García-Montero

et al. 2021

JCM

111

View full text Add to dashboard Cite

Chronic venous disease (CVD) is a multifactorial condition affecting an important percentage of the global population. It ranges from mild clinical signs, such as telangiectasias or reticular veins, to severe manifestations, such as venous ulcerations. However, varicose veins (VVs) are the most common manifestation of CVD. The explicit mechanisms of the disease are not well-understood. It seems that genetics and a plethora of environmental agents play an important role in the development and progression of CVD. The exposure to these factors leads to altered hemodynamics of the venous system, described as ambulatory venous hypertension, therefore promoting microcirculatory changes, inflammatory responses, hypoxia, venous wall remodeling, and epigenetic variations, even with important systemic implications. Thus, a proper clinical management of patients with CVD is essential to prevent potential harms of the disease, which also entails a significant loss of the quality of life in these individuals. Hence, the aim of the present review is to collect the current knowledge of CVD, including its epidemiology, etiology, and risk factors, but emphasizing the pathophysiology and medical care of these patients, including clinical manifestations, diagnosis, and treatments. Furthermore, future directions will also be covered in this work in order to provide potential fields to explore in the context of CVD.

show abstract

Section: Clinical Manifestationsmentioning

confidence: 99%

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Ortega

Fraile-Martínez

García-Montero

et al. 2021

JCM

111

View full text Add to dashboard Cite

show abstract

“…Data present in the literature demonstrate that normally with sclerotherapy, clearance after one treatment varies from 50% to 84% of patients. 8 Also the data show that, to achieve full clearance, up to six treatments may be needed. 9 Transcutaneous laser therapy is the second preferred therapeutic option.…”

Section: Discussionmentioning

confidence: 99%

980 nm laser endo‐perivenous treatment of lower limb reticular veins and telangiectasias. Technical notes

PALOMBI¹,

Morelli

2023

Lasers Surg Med

View full text Add to dashboard Cite

Introduction: For several years, the venous aesthetic problem has been tackled mainly with sclerotherapy techniques. In recent years, laser techniques have been added, both surface (transdermal) and endo-perivenous, performed with small optical fibers (100-200 μm) and low intensities in terms of LEED and Watt. The endo-perivenous technique has extended the possibilities of laser treatment also to the nourishing veins, to telangiectasias resistant to therapies with sclerosing agents and/or transdermal lasers and to vessels with larger diameters (1-3 mm) and depths >1.3 mm. Materials and Methods: We report a series of 20 patients affected by reticular veins and telangiectasias of the lower limbs (CEAP C1-2) treated with endoperivenous technique. The most used setting was: 3 W (range: 2-4 W) with a mean fluence delivered of 11.25 J/cm (range: 6-18) in pulse mode with 980 nm laser, 200 μm fiber after a preventive skin cooling. Scheduled follow-up occurred 20 and 60 days after treatment. Results: Total technical success, understood as complete obliteration of all treated vessels, was achieved in 70% of cases (14/20) after just one treatment. The most observed early local complications were erythema, vesicles, and small cutaneous eschars that regressed in 3 weeks. At 60-day follow-up, just one complication was observed: a small area of hyperpigmentation (5%). In this case, chemical peel procedures was performed with good clinical results. Conclusions: Endoperivenous laser treatment represents an effective and valid tool for the treatment of teleangectasias and reticular varicose veins.

show abstract

“…Spider veins measure less than 1.0 mm in diameter and occur primarily in the lower extremities. Reticular veins are located in the subcutaneous tissue, they measure less than 3 mm in diameter and are often tortuous (twisted) and widened (Nakano et al, 2017).…”

Section: Assessmentmentioning

confidence: 99%

Lower limb assessment

Mitchell

Elbourne

2020

Br J Nurs

View full text Add to dashboard Cite

Lower limb Assessment in Adult Patients 'at a glance clinical review article for commissioned series'. Chronic venous insufficiency Chronic venous disease is a common problem that is often overlooked by healthcare practitioners. It is estimated to affect ≥30% of the adult population although this is difficult to calculate due to a significant number of under-diagnosis (Radak et al., 2016). Venous disease is considered to cost is between 600-900 million to 2.5 million euros a year across Western Europe (Radak et al., 2016; Rabe and Pannier 2010). These costs include investigations, treatment and management, deterioration of quality of life and loss of working days (Rabe and Pannier 2010). The main risk factors of chronic venous insufficiency (CVI) increases with age and obesity. It is therefore recognised that the prevalence is slowly rising increasing the socioeconomic burden (Rabe and Pannier, 2010). Venous blood flows from the skin to the superficial veins (found in the subcutaneous tissue), which drain into the deep veins. Bicuspid valves in the veins function to keep blood moving in one direction and prevent backflow of blood. Venous insufficiency is an impaired flow of blood through the veins caused by valve incompetence (where the values are unable to close This article will:  Provide clinical guidance on early indications for chronic venous insufficiency

show abstract

Treatment for telangiectasias and reticular veins

Abstract: This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the effects of sclerotherapy, laser therapy, intensive pulsed light (IPL), thermocoagulation, and microphlebectomy treatment for telangiectasias and reticular veins.

Cited by 13 publications

References 21 publications

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

980 nm laser endo‐perivenous treatment of lower limb reticular veins and telangiectasias. Technical notes

Lower limb assessment

Contact Info

Product

Resources

About